As the crypto market gears up for another major run, Mutuum Finance (MUTM) and Cardano (ADA) are emerging as standout coins in 2025’s high-ROI race. Mutuum Finance (MUTM) is at presale stage 6 at a price of $0.035. Mutuum Finance will be up by 14.29% to $0.04 in stage 7. Investors who enter in this […]As the crypto market gears up for another major run, Mutuum Finance (MUTM) and Cardano (ADA) are emerging as standout coins in 2025’s high-ROI race. Mutuum Finance (MUTM) is at presale stage 6 at a price of $0.035. Mutuum Finance will be up by 14.29% to $0.04 in stage 7. Investors who enter in this […]

Top Cryptos to Buy Now With the Highest ROI Potential in 2025

As the crypto market gears up for another major run, Mutuum Finance (MUTM) and Cardano (ADA) are emerging as standout coins in 2025’s high-ROI race. Mutuum Finance (MUTM) is at presale stage 6 at a price of $0.035. Mutuum Finance will be up by 14.29% to $0.04 in stage 7. Investors who enter in this phase will get at least 400% returns when the token is listed. Mutuum Finance has already crossed more than $15.25 million and over 15850 investors. The project is closely watched by investors positioning themselves for the next crypto win.

Cardano (ADA) Holds Steady Amid 2025 Market Anticipation

Cardano (ADA) is currently trading at $0.86, showing relatively stable performance as the broader market prepares for a potentially active year ahead. Analysts note that ADA continues to focus on network upgrades and ecosystem growth, with price movement largely influenced by overall market sentiment and institutional positioning. As attention shifts toward both established projects like Cardano and emerging DeFi protocols, newer players such as Mutuum Finance are also beginning to attract attention.

Mutuum Finance (MUTM) Dual-Layer DeFi Lending Framework

Mutuum Finance (MUTM) is an innovative non-custodial DeFi protocol. The project is capable of Peer-to-Contract lending and Peer-to-Peer lending with great flexibility and efficiency of operations. Peer-to-Contract utilizes the smart contract feature to lend with minimal or no human interference. Peer-to-Peer eliminates middlemen and has lenders and borrowers directly transact and exchange with each other. The model is extremely easy to handle risky assets like meme coins.

Mutuum Finance (MUTM) Presale Achieves Success

Mutuum Finance (MUTM) is blazing with presale making headlines. It is currently at stage 6 at $0.035. It will also shoot up by 14.29% to $0.04 in the next phase. Investor demand is rising with the project already reaching over $15.25 million and already boasting a token holder base of over 15850. 

Mutuum Finance Launches USD-Pegged Stablecoin

Mutuum Finance (MUTM) is launching its new overcollateralized USD-pegged stablecoin on the Ethereum blockchain. With a strong and long-lasting foundation, the stablecoin has extremely high chances of being safe and stable for several decades to come. The project also boasts a 95.0 trust score as indicated by a Certik audit.

Mutuum Finance (MUTM) has also introduced its Bug Bounty Program with a reward of $50,000 USDT. It has four severities to be resolved that are critical, major, minor, and low.

Mutuum Finance Launches Exciting Giveaway

Mutuum Finance (MUTM) is conducting a $100,000 giveaway as it wishes to expand its community. 10 lucky individuals who participate in the giveaway will get an opportunity to win MUTM tokens to the value of $10,000.

Roadmap to Sustainable Development

Mutuum Finance (MUTM) has designed its tokenomics with one intention in mind: to generate long-term value, sustain market health and liquidity, and protect against long-term inflation. Instead of striving for short-term gain, the project is designed to offer steady growth and stability over the long term.

Mutuum Finance (MUTM) has raised over $15.25 million with more than 15,850 participants entering at $0.035 in Stage 6. With Stage 7 priced at $0.04 and a roadmap designed for long-term liquidity, its dual lending system and USD-pegged stablecoin are attracting both retail and institutional attention. Investors looking to maximize ROI ahead of 2025’s market upswing may find this stage one of the most strategic entry points before the next valuation jump.

Mutuum Finance (MUTM) has already secured over $15.25 million from 15,850+ early backers, pricing Stage 6 at $0.035 with a planned increase to $0.04 in Stage 7. With projections of 400% returns upon listing and a steadily increasing presale trajectory, this window offers one of the most favorable risk-reward entries before demand intensifies further. Investors aiming to position themselves early in 2025’s DeFi expansion may find Mutuum Finance an opportunity worth acting on before the next price surge.

For more information about Mutuum Finance (MUTM) visit the links below:

Website: https://mutuum.com/

Linktree: https://linktr.ee/mutuumfinance

Market Opportunity
TOP Network Logo
TOP Network Price(TOP)
$0,000096
$0,000096$0,000096
0,00%
USD
TOP Network (TOP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26